Latest filing published 02 Dec 2025 for Elanco Animal Health Inc.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Denise Scots-Knight is a declared insider at 2 companies (board member); the most frequent names are Elanco Animal Health Inc and Mereo BioPharma Group plc. In total, 14 filings cover trades dated from 11 April 2019 to 28 November 2025.
Sales make up the whole of the open-market record (4 sales, €778k). The rest of the record consists of 8 share grants and 2 option exercises.
The newest entry dates from 2 December 2025: a share grant, in Elanco Animal Health Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations